Treatment of senescence-related chronic disease, as shown by recent studies with DPP4 inhibitors that ameliorated atherosclerosis in type 2 DM patients [30, 31], prevented vascular aging [32] and protected chondrocytes from TNF-α-induced senescence [33]. The gene discussed is DPP4; the disease is atherosclerosis.